HPLC determination of levodopa in human plasma for study of the pharmacokinetics of levodopa/benserazide dispersible tablets
Jing YUAN,Ping-Quan WANG,Hui-di YANG,Yan-qiu FEI,Fu-Rong AN,Sheng-Rong GE,An-guo SHI
DOI: https://doi.org/10.3321/j.issn:1003-3734.2001.02.010
2001-01-01
Abstract:Objective:During study of pharmacokinetics of levodo pa/benserazide dispersible tablets，a HPLC method for determination of levodopa in human plasma was developed.Methods:Waters 2010 system was adopt ed with a 474 fluorecence detector(λEx=278nm,λEm=325nm),a Lichrosp her 100 C18 column(5μm,250 mm×4 mm),a mobile phase (pH 3.7) consisted of 90% solution (containing EDTA 0.08 mmol/L,KH2PO4 70 mmol/L and sodium hepta nesulfonate 2.08 mmol/L)and 10% methanol and using a flow rate of 1.0 ml/min.Aft er deproteinized with perchloric acid,plasma sample was directly injected. Results:The method have a recovery range of 95.50%～102.55%,a minimum d etection limit of 0.25ng,a linear range of 0.125～4.0 μg/ml within-day RSD<4.2 9%(n=4),between-day RSD<6.73%(n=4).After oral administration of 200 mg of levodopa/benserazide dispersible tablet,the disposition was conformed to a two-compartment model with AUC=(406.09±85.02)(μg*min)/ml,C max=(3.55±0.91)μg/ml,Tmax=(31.38±7.74) min and t1/2α=(24.09±6 .02)min.Compared with levodopa tablet,the Tmax and t1/2α showed sta tistical difference.The relative bioavailability was (97.63±11.94)%.Con clusion:A s imple,sensitive and accurate method for HPLC determination of levodopa in human plasma was developed,and levodopa/benserazide dispersible tablet was absorbed an d reached peak-time quickly than levodopa tablet.the method has been used in th e study of pharmacokinetics of levodopa/benserazide dispersible tablets.